EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Repurposed small molecule toxin inhibitors neutralise a diversity of venoms from the Neotropical viperid snake genus Bothrops

Rachel H Clare iD, Adam Westhorpe, Emma Stars, Taline D Kazandjian iD, Laura-Oana Albulescu iD, Stefanie K Menzies iD, Nicholas R Casewell iD

eLife · 2026

DOI: 10.7554/elife.110419 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, 2026. Verfasst von Rachel H Clare und 6 weiteren Autor:innen. Beteiligte Einrichtung: Biology Department, Edge Hill University, Ormskirk, United Kingdom. Hauptthemen laut MEDLINE: Bothrops, Crotalid Venoms, Antivenins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Wellcome.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Snakebite globally claims more than 100,000 lives per year and results in morbidity for 400,000 survivors. Current treatment uses antibody-based antivenoms which are constrained by their efficacy, safety, and cost. In this study we evaluated the efficacy of previously described repurposed drugs against viperid snakes of the medically important Bothrops genus. Despite variable toxin representation and bioactivity across this central and south American genus, we found that the lead inhibitors targeting metalloproteinases (marimastat and DMPS) and phospholipases (varespladib) demonstrated pan-species neutralisation in enzymatic assays, whilst nafamostat (serine protease inhibitor) had variable activity. The metalloproteinase inhibitors protected against the procoagulant and haemorrhagic effects of several venoms in phenotypic assays. Collectively these findings demonstrate that repurposed drugs may be of great value as early interventions for the treatment of bothropic envenoming in the Neotropics and thus provide a strong rationale for their progression into future preclinical and clinical evaluation for snakebite indication.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BothropsCrotalid VenomsAntiveninsAnimalsMetalloproteasesSnake BitesHydroxamic AcidsAcetatesIndolesKeto Acids

Stichwörter der Autor:innen

BothropsDMPSbiochemistrychemical biologychickenepidemiologyglobal healthmarimastatsnakebitevarespladibvenom

Substanzen

Crotalid VenomsAntiveninsmarimastatvarespladibMetalloproteasesHydroxamic AcidsAcetatesIndolesKeto Acids

Autor:innen und Institutionen

  • Biology Department, Edge Hill University, Ormskirk, United Kingdom.
  • Centre for Snakebite Research and Interventions, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
  • Biomedical & Life Sciences, Lancaster University, Bailrigg, United Kingdom.

ORCID-Profile: Rachel H Clare, Taline D Kazandjian, Laura-Oana Albulescu, Stefanie K Menzies, Nicholas R Casewell

Förderung

  • Wellcome Trust
  • Wellcome

Zitieren

APA

Clare, R. H., Westhorpe, A., Stars, E., Kazandjian, T. D., Albulescu, L. O., Menzies, S. K., & Casewell, N. R. (2026). Repurposed small molecule toxin inhibitors neutralise a diversity of venoms from the Neotropical viperid snake genus Bothrops. eLife. https://doi.org/10.7554/elife.110419

Vancouver

Clare RH, Westhorpe A, Stars E, Kazandjian TD, Albulescu LO, Menzies SK, et al. Repurposed small molecule toxin inhibitors neutralise a diversity of venoms from the Neotropical viperid snake genus Bothrops. eLife. 2026. doi:10.7554/elife.110419

BibTeX
@article{Clare2026,
  author = {Clare, Rachel H and Westhorpe, Adam and Stars, Emma and Kazandjian, Taline D and Albulescu, Laura-Oana and Menzies, Stefanie K and Casewell, Nicholas R},
  title = {Repurposed small molecule toxin inhibitors neutralise a diversity of venoms from the Neotropical viperid snake genus Bothrops},
  journal = {eLife},
  year = {2026},
  doi = {10.7554/elife.110419}
}
Kostenlos starten →